Neurology News

Samsung Electronics health care subsidiary NeuroLogica Corp. announced it has received 510(k) clearance from the FDA for its BodyTom 64, a mobile head-to-toe CT scanner that can be used for a variety of health care needs.

Posterior cervical foraminotomy was noninferior to anterior cervical discectomy with fusion in success rate and arm pain at 1 year in patients with cervical radiculopathy, researchers reported in JAMA Neurology.

The Feinstein Institutes for Medical Research has been awarded a $3.6 million grant, to be distributed over 5 years, from the New York State Department of Health for the study of spinal cord simulation and novel brain implant technology.

Results from the EVOLVE-MS-1 study show Vumerity was effective and well-tolerated over 96 weeks in patients with relapsing-remitting MS compared with dimethyl fumarate, according to a presentation at ECTRIMS 2022.

Drinking any amount of alcohol during pregnancy was associated with changes and delays in fetal brain development, according to data presented at the Radiological Society of North America annual meeting.

Klotho protein levels in cerebrospinal fluid and plasma were associated with clinical stages of Alzheimer’s disease, cognitive decline, and amyloid and tau burden, independent of KL-VS heterozygosity status, according to research.

Irrigation at body temperature was superior to room temperature in the evacuation of chronic subdural hematoma, resulting in fewer recurrences and optimized patient outcomes, researchers reported in JAMA Neurology.

Optimizing collaborative care medication was modestly more effective than cognitive behavioral therapy in reducing pain impact among United States veterans, researchers reported in JAMA Network Open.

Lysogene has announced topline results from its phase 2/3 study evaluating LYS-SAF302, an investigational gene therapy for the treatment of mucopolysaccharidosis type IIIA, or Sanfilippo syndrome.

An increased risk for Parkinson’s disease was associated with a range of factors, comorbidities and prodromal features, some of which may appear 5 to 10 years prior to diagnosis, according to a study in JAMA Neurology.